Search

Your search keyword '"National Institute of Public Health [Romania] (INSP)"' showing total 8 results
Start Over Author "National Institute of Public Health [Romania] (INSP)"
8 results on '"National Institute of Public Health [Romania] (INSP)"'

1. Occupational Exposure to Polycyclic Aromatic Hydrocarbons and Lung Cancer Risk: Results from a Pooled Analysis of Case–Control Studies (SYNERGY)

Author

Olsson, Ann, Guha, Neela, Bouaoun, Liacine, Kromhout, Hans, Peters, Susan, Siemiatycki, Jack, Ho, Vikki, Gustavsson, Per, Boffetta, Paolo, Vermeulen, Roel, Behrens, Thomas, Bruning, Thomas, Kendzia, Benjamin, Guénel, Pascal, Luce, Danièle, Karrasch, Stefan, Wichmann, Heinz-Erich, Consonni, Dario, Landi, Maria Teresa, Caporaso, Neil E, Merletti, Franco, Mirabelli, Dario, Richiardi, Lorenzo, Jöckel, Karl-Heinz, Ahrens, Wolfgang, Pohlabeln, Hermann, Tardon, Adonina, Zaridze, David, Field, John K, Lissowska, Jolanta, Świątkowska, Beata, McLaughlin, John R, Demers, Paul A, Bencko, Vladimir, Foretova, Lenka, Janout, Vladimir, Pandics, Tamas, Fabianova, Eleonora, Mates, Dana, Forastiere, Francesco, Bueno-de-Mesquita, Bas, Schüz, Joachim, Straif, Kurt, IRAS OH Epidemiology Chemical Agents, dIRAS RA-2, IRAS OH Epidemiology Chemical Agents, dIRAS RA-2, Centre International de Recherche contre le Cancer - International Agency for Research on Cancer (CIRC - IARC), Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), Utrecht University [Utrecht], Université de Montréal (UdeM), Karolinska Institutet [Stockholm], University of Bologna/Università di Bologna, Stony Brook University [SUNY] (SBU), State University of New York (SUNY), Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), École des Hautes Études en Santé Publique [EHESP] (EHESP), Ludwig Maximilian University [Munich] (LMU), Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, National Cancer Institute [Bethesda] (NCI-NIH), National Institutes of Health [Bethesda] (NIH), Department of Medical Sciences [Turin, Italy] (DMS), Università degli studi di Torino = University of Turin (UNITO), Universitätsklinikum Essen [Universität Duisburg-Essen] (Uniklinik Essen), Universität Bremen, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Leibniz Association, University of Oviedo, N.N. Blokhin National Medical Research Center of Oncology, University of Liverpool, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (MCMCC), Nofer Institute of Occupational Medicine (NIOM), University of Toronto, Occupational Cancer Research Centre, First Faculty of Medicine, Charles University [Prague] (CU), Masaryk Memorial Cancer Institute (MMCI), Faculty of Health Sciences [UEF, Kuopio, Finland], University of Eastern Finland, National Public Health Center, National Institute of Public Health [Romania] (INSP), Azienda Sanitaria Locale [ROMA] (ASL), National Institute for Public Health and the Environment [Bilthoven] (RIVM), Instituto de Salud Global - Institute For Global Health [Barcelona] (ISGlobal), Boston College (BC), and Chard-Hutchinson, Xavier

Subjects
Male, Lung Neoplasms, Epidemiology, Medizin, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, [SDV.CAN] Life Sciences [q-bio]/Cancer, Oncology, polycyclic aromatic hydrocarbons, benzo[a]pyrene, lung cancer, occupational exposures, case-control study, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, Case-Control Studies, Occupational Exposure, Carcinogens, Humans, [SDV.MHEP.PSR] Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, Female, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Polycyclic Aromatic Hydrocarbons, Lung
Abstract

German Social Accident Insurance (DGUV) between 2007 and 2011, Olsson A, Guha N, Bouaoun L, Kromhout H, Peters S, Siemiatycki J, Ho V, Gustavsson P, Boffetta P, Vermeulen R, Behrens T, Brüning T, Kendzia B, Guénel P, Luce D, Karrasch S, Wichmann HE, Consonni D, Landi MT, Caporaso NE, Merletti F, Mirabelli D, Richiardi L, Jöckel KH, Ahrens W, Pohlabeln H, Tardón A, Zaridze D, Field JK, Lissowska J, Świątkowska B, McLaughlin JR, Demers PA, Bencko V, Foretova L, Janout V, Pándics T, Fabianova E, Mates D, Forastiere F, Bueno-de-Mesquita B, Schüz J, Straif K

Published
2022

2. Genetic analysis of lung cancer and the germline impact on somatic mutation burden

Author

Gabriel, AAG, Atkins, JR, Penha, RCC, Smith-Byrne, K, Gaborieau, V, Voegele, C, Abedi-Ardekani, B, Milojevic, M, Olaso, R, Meyer, V, Boland, A, Deleuze, JF, Zaridze, D, Mukeriya, A, Swiatkowska, B, Janout, V, Schejbalová, M, Mates, D, Stojšić, J, Ognjanovic, M, consortium, ILCCO, Witte, JS, Rashkin, SR, Kachuri, L, Hung, RJ, Kar, S, Brennan, P, Sertier, A-S, Ferrari, A, Viari, A, Johansson, M, Amos, CI, Foll, M, McKay, JD, Centre International de Recherche contre le Cancer - International Agency for Research on Cancer (CIRC - IARC), Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), University of Oxford, Université Paris-Saclay, N.N. Blokhin Russian Cancer Research Center, Nofer Institute of Occupational Medicine (NIOM), Palacky University Olomouc, Charles University [Prague] (CU), National Institute of Public Health [Romania] (INSP), University Clinical Centre of Serbia, International Organisation for Cancer Prevention and Research, University of California [San Francisco] (UC San Francisco), University of California (UC), St Jude Children's Research Hospital, Centre for Systems Biology, Lunenfeld Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada, University of Bristol [Bristol], Fondation Synergie Lyon Cancer [Lyon], Centre Léon Bérard [Lyon], Equipe de recherche européenne en algorithmique et biologie formelle et expérimentale (ERABLE), Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Inria Lyon, Institut National de Recherche en Informatique et en Automatique (Inria), Baylor College of Medicine (BCM), and Baylor University

Subjects
Cancer Research, Germ Cells, Lung Neoplasms, Oncology, [SDV]Life Sciences [q-bio], Mutation, Humans, Genetic Predisposition to Disease, ICEP, Polymorphism, Single Nucleotide, Genome-Wide Association Study
Abstract

Background Germline genetic variation contributes to lung cancer (LC) susceptibility. Previous genome-wide association studies (GWAS) have implicated susceptibility loci involved in smoking behaviors and DNA repair genes, but further work is required to identify susceptibility variants. Methods To identify LC susceptibility loci, a family history-based genome-wide association by proxy (GWAx) of LC (48 843 European proxy LC patients, 195 387 controls) was combined with a previous LC GWAS (29 266 patients, 56 450 controls) by meta-analysis. Colocalization was used to explore candidate genes and overlap with existing traits at discovered susceptibility loci. Polygenic risk scores (PRS) were tested within an independent validation cohort (1 666 LC patients vs 6 664 controls) using variants selected from the LC susceptibility loci and a novel selection approach using published GWAS summary statistics. Finally, the effects of the LC PRS on somatic mutational burden were explored in patients whose tumor resections have been profiled by exome (n = 685) and genome sequencing (n = 61). Statistical tests were 2-sided. Results The GWAx–GWAS meta-analysis identified 8 novel LC loci. Colocalization implicated DNA repair genes (CHEK1), metabolic genes (CYP1A1), and smoking propensity genes (CHRNA4 and CHRNB2). PRS analysis demonstrated that these variants, as well as subgenome-wide significant variants related to expression quantitative trait loci and/or smoking propensity, assisted in LC genetic risk prediction (odds ratio = 1.37, 95% confidence interval = 1.29 to 1.45; P Conclusions This study has expanded the number of LC susceptibility loci and provided insights into the molecular mechanisms by which these susceptibility variants contribute to LC development.

Published
2022

3. Application of two job indices for general occupational demands in a pooled analysis of case–control studies on lung cancer

Author

Neil E. Caporaso, Ann Olsson, Dana Mates, Cristina Fortes, Tamás Pándics, Simonato Lorenzo, Jolanta Lissowska, Kurt Straif, Beate Pesch, Jan Hovanec, Guillermo Fernández-Tardón, Hans Kromhout, Pascal Guénel, Karl-Heinz Jöckel, Eleonora Fabianova, Roel Vermeulen, Wolfgang Ahrens, Stefan Karrasch, Hermann Pohlabeln, John K. Field, Joachim Schüz, Vladimir Bencko, Beata Świątkowska, Thomas Brüning, Dario Consonni, Danièle Luce, Thomas Behrens, Maria Teresa Landi, David I. Conway, John R. McLaughlin, Per Gustavsson, Paolo Boffetta, Marie-Élise Parent, Vladimir Janout, Franco Merletti, Lorenzo Richiardi, Lenka Foretova, Heinz-Erich Wichmann, David Zaridze, Swaantje Casjens, Paul A. Demers, Jack Siemiatycki, IRAS OH Epidemiology Chemical Agents, dIRAS RA-2, Ruhr-Universität Bochum [Bochum], Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CR CHUM), Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal (UdeM)-Université de Montréal (UdeM), University of Glasgow, Centre International de Recherche contre le Cancer - International Agency for Research on Cancer (CIRC - IARC), Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, École des Hautes Études en Santé Publique [EHESP] (EHESP), Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Ruhrlandklinik University Hospital, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Leibniz Association, Universität Bremen, Helmholtz Zentrum München = German Research Center for Environmental Health, Ludwig-Maximilians-Universität München (LMU), Karolinska Institute, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Università degli studi di Torino = University of Turin (UNITO), Azienda Ospedale Università di Padova = Hospital-University of Padua (AOUP), Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), University of Toronto, National Cancer Institute [Bethesda] (NCI-NIH), National Institutes of Health [Bethesda] (NIH), Universidad de Oviedo [Oviedo], CIBER de Epidemiología y Salud Pública (CIBERESP), N.N. Blokhin National Medical Research Center of Oncology, Nofer Institute of Occupational Medicine (NIOM), National Public Health Centre, Medical University of Warsaw - Poland, University of Liverpool, National Institute of Public Health [Romania] (INSP), Charles University [Prague] (CU), Masaryk Memorial Cancer Institute (MMCI), Palacky University Olomouc, Universiteit Utrecht, Alma Mater Studiorum Università di Bologna [Bologna] (UNIBO), Stony Brook University [SUNY] (SBU), State University of New York (SUNY), German Social Accident Insurance [FP 271], Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique )-Institut National de la Santé et de la Recherche Médicale (INSERM)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Université d'Angers (UA), Helmholtz-Zentrum München (HZM), University of Turin, University Hospital of Padua, Masaryk Memorial Cancer Institute (RECAMO), Chard-Hutchinson, Xavier, Hovanec J., Siemiatycki J., Conway D.I., Olsson A., Guenel P., Luce D., Jockel K.-H., Pohlabeln H., Ahrens W., Karrasch S., Wichmann H.-E., Gustavsson P., Consonni D., Merletti F., Richiardi L., Simonato L., Fortes C., Parent M.-E., McLaughlin J.R., Demers P., Landi M.T., Caporaso N., Fernandez-Tardon G., Zaridze D., Swiatkowska B., Pandics T., Lissowska J., Fabianova E., Field J.K., Mates D., Bencko V., Foretova L., Janout V., Kromhout H., Vermeulen R., Boffetta P., Straif K., Schuz J., Casjens S., Pesch B., Bruning T., and Behrens T.

Subjects
Male, Lung Neoplasms, Occupational prestige, Short Communication, [SDV]Life Sciences [q-bio], Medizin, Logistic regression, 03 medical and health sciences, occupational demand, 0302 clinical medicine, Occupational Exposure, medicine, Odds Ratio, case–control, Humans, cancer, Risk factor, Occupations, Lung cancer, job index, business.industry, Environmental and Occupational Health, Smoking, Public Health, Environmental and Occupational Health, Cancer, Odds ratio, Social prestige, medicine.disease, 030210 environmental & occupational health, Confidence interval, Key terms job index, [SDV] Life Sciences [q-bio], lung cancer, Tumor subtype, Case-Control Studies, Female, Public Health, Public aspects of medicine, RA1-1270, business, Psychosocial, Tumor Subtype, Job index, Social Prestige, Demography
Abstract

The German Social Accident Insurance supported this study (grant number FP 271)., Hovanec J, Siemiatycki J, Conway DI, Olsson A, Guenel P, Luce D, Jöckel KH, Pohlabeln H, Ahrens W, Karrasch S, Wichmann HE, Gustavsson P, Consonni D, Merletti F, Richiardi L, Lorenzo S, Fortes C, Parent MÉ, McLaughlin JR, Demers P, Landi MT, Caporaso N, Fernández-Tardón G, Zaridze D, Świątkowska B, Pándics T, Lissowska J, Fabianova E, Field JK, Mates D, Bencko V, Foretova L, Janout V, Kromhout H, Vermeulen R, Boffetta P, Straif K, Schüz J, Casjens S, Pesch B, Brüning T, Behrens T.

Published
2021

4. Occupations and the Risk of Head and Neck Cancer: A Pooled Analysis of the International Head and Neck Cancer Epidemiology (INHANCE) Consortium

Author

Kristina Kjærheim, Dana Hashim, Gwenn Menvielle, Hermann Brenner, Peter Thomson, Prerna Khetan, Diego Serraino, Pagona Lagiou, Carlo La Vecchia, Maria Paula Curado, Mia Hashibe, Lorenzo Richiardi, Yuan Chin Amy Lee, Danièle Luce, Wolfgang Ahrens, Joshua E. Muscat, Thomas L. Vaughan, Dana Mates, Isabelle Stücker, Heribert Ramroth, Paolo Boffetta, Victor Wünsch-Filho, David I. Conway, Ana M. B. Menezes, Icahn School of Medicine at Mount Sinai [New York] (MSSM), Institut de recherche en santé, environnement et travail (Irset), Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique )-Institut National de la Santé et de la Recherche Médicale (INSERM)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Université d'Angers (UA), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, International Prevention Research Institute (IPRI), Universidade Federal de Pelotas = Federal University of Pelotas (UFPel), Universidade de São Paulo (USP), Leibniz Institute for Prevention Research and Epidemiology - BIPS, Leibniz Association, National and Kapodistrian University of Athens (NKUA), University of Turin, Cancer Registry of Norway, University of Glasgow, The University of Hong Kong (HKU), Penn State College of Medicine, Penn State System-Pennsylvania Commonwealth System of Higher Education (PCSHE), National Institute of Public Health [Romania] (INSP), Heidelberg University Hospital [Heidelberg], Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Universität Heidelberg [Heidelberg], German Cancer Research Center - Deutsches Krebsforschungszentrum [Heidelberg] (DKFZ), University of Utah School of Medicine [Salt Lake City], Università degli Studi di Milano [Milano] (UNIMI), International Agency for Cancer Research (IACR), The INHANCE Consortium was supported by NIH grants NCI R03CA113157 and NIDCR R03DE016611. Studies participating in the pooled analysis were supported by: Latin America study: Fondo para la Investigacion Cientifica y Tecnologica (FONCYT) Argentina, IMIM (Barcelona), Fundaco de Amparo a` Pesquisa no Estado de Sao Paulo (FAPESP) [No 01/01768–2], and European Commission [IC18-CT97–0222]. Sao Paulo: Sao Paulo Research Foundation (FAPESP) (GENCAPO 04/12054–9, 10/51168–0). Western Europe multicenter (ARCAGE): European Community (5th Framework Programme) grant no QLK1-CT-2001-00182. New York multicenter: NY multicenter study: NIH [P01CA068384 K07CA104231]. Central Europe multicenter (INCO): Central Europe study: World Cancer Research Fund and the European Commission INCO-COPERNICUS Program [Contract No. IC15- CT98–0332]. Tampa study: NIH [P01CA068384, K07CA104231, R01DE013158] Germany-Heidelberg: Germany-Heidelberg study: grant No. 01GB9702/3 from the German Ministry of Education and Research. Seattle-Leo: Seattle-LEO study: NIH[R01CA030022]. MSKCC: MSKCC study: NIH [R01CA051845]. Germany-Saarland: Saarland study: Ministry of Science, Research and Arts Baden-Wurttemberg.. France multicenter (ICARE): French National Research Agency (ANR), French National Cancer Institute (INCA), French Agency for Food, Environmental and Occupational Health and Safety (ANSES), French Association for Research on Cancer (ARC), Fondation pour la Recherche Médicale (FRM), French Institute for Public Health Surveillance (InVS), Fondation de France, Ministry of Labour, Ministry of Health, LUCE, Danièle, Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Universidade de São Paulo = University of São Paulo (USP), Università degli studi di Torino = University of Turin (UNITO), Pennsylvania Commonwealth System of Higher Education (PCSHE)-Penn State System, Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Università degli Studi di Milano = University of Milan (UNIMI), Khetan P., Boffetta P., Luce D., Stucker I., Curado M.P., Menezes A., Wunsch-Filho V., Ahrens W., Lagiou P., Serraino D., Richiardi L., Kjaerheim K., Conway D., Thomson P., Muscat J., Mates D., Ramroth H., Menvielle G., Vaughan T.L., Brenner H., Lee Y.-C.A., La Vecchia C., Hashibe M., Hashim D., and Universität Heidelberg [Heidelberg] = Heidelberg University

Subjects
medicine.medical_specialty, Databases, Factual, Population, Logistic regression, Article, Pooled, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Epidemiology, medicine, Humans, education, Cancer, education.field_of_study, Occupation, business.industry, Head and neck cancer, Public Health, Environmental and Occupational Health, Odds ratio, medicine.disease, 030210 environmental & occupational health, Confidence interval, Europe, Occupational Diseases, Latin America, Logistic Models, Head and Neck Neoplasms, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, Head, Larynx, Neck, Attributable risk, North America, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, business, Demography
Abstract

Objective: To investigate the associations between head and neck cancer\ud (HNC) risk and occupations. Methods: We harmonized data on occupations\ud in a pooled analysis of 8839 HNC cases and 13,730 controls in International\ud Head and Neck Cancer Epidemiology (INHANCE) consortium. Logistic\ud regression was used to estimate odds ratios (ORs) for associations of\ud occupations and HNC risk. Population attributable fraction (PAF)\ud for occupations was calculated using the formula PEC (OR 1)/OR.1\ud Results: Trend of increasing HNC risk was found with increasing duration\ud of employment for many occupations, including cooks (OR ¼ 1.36; 95%\ud confidence interval [CI] 1.09 to 1.68), cleaners (OR ¼ 1.38; 95% CI 1.13 to\ud 1.69), painters (OR ¼ 1.82; 95% CI 1.42 to 2.35). The PAF for a priori\ud occupations was 14.5% (95% CI 7.1% to 21.9%) for HNC. Conclusions: We\ud found associations between certain occupations and HNC risks, including for\ud subsites, with a duration– response relationship.

Published
2019

5. Lung cancer and socioeconomic status in a pooled analysis of case-control studies

Author

Hovanec, J., Siemiatycki, J., Conway, D. I., Olsson, A., Stücker, I., Guida, F., Jockel, K. -H., Pohlabeln, H., Ahrens, W., Brüske, I., Wichmann, H. -E., Gustavsson, P., Consonni, D., Merletti, F., Richiardi, L., Simonato, L., Fortes, C., Parent, M. -E., McLaughlin, J., Demers, P., L, i, M. T., Caporaso, N., Tardón, A., Zaridze, D., Szeszenia-Dabrowska, N., Rudnai, P., Lissowska, J., Fabianova, E., Field, J., Dumitru, R. S., Bencko, V., Foretova, L., Janout, V., Kromhout, H., Vermeulen, R., Boffetta, P., Straif, K., Schüz, J., Kendzia, B., Pesch, B., Brüning, T., Behrens, T., Hovanec, J. and Siemiatycki, J. and Conway, D.I. and Olsson, A. and Stücker, I. and Guida, F. and Jockel, K.-H. and Pohlabeln, H. and Ahrens, W. and Brüske, I. and Wichmann, H.-E. and Gustavsson, P. and Consonni, D. and Merletti, F. and Richiardi, L. and Simonato, L. and Fortes, C. and Parent, M.-E. and McLaughlin, J. and Demers, P. and Landi, M.T. and Caporaso, N. and Tardón, A. and Zaridze, D. and Szeszenia-Dabrowska, N. and Rudnai, P. and Lissowska, J. and Fabianova, E. and Field, J. and Dumitru, R.S. and Bencko, V. and Foretova, L. and Janout, V. and Kromhout, H. and Vermeulen, R. and Boffetta, P. and Straif, K. and Schüz, J. and Kendzia, B. and Pesch, B. and Brüning, T. and Behrens, T., Ruhr-Universität Bochum [Bochum], Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal (UdeM), University of Glasgow, Karolinska Institutet [Stockholm], Centre de recherche en épidémiologie et santé des populations (CESP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Sud - Paris 11 (UP11)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Universitätsklinikum Essen [Universität Duisburg-Essen] (Uniklinik Essen), Leibniz Institute for Prevention Research and Epidemiology - BIPS, Leibniz Association, University of Bremen, Helmholtz-Zentrum München (HZM), Technische Universität Munchen - Université Technique de Munich [Munich, Allemagne] (TUM), Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, University of Turin, Universita degli Studi di Padova, Istituto Dermopatico dell'Immacolata, Institut Armand Frappier (INRS-IAF), Institut National de la Recherche Scientifique [Québec] (INRS)-Réseau International des Instituts Pasteur (RIIP), Public Health Ontario - Santé publique Ontario, Occupational Cancer Research Centre, National Cancer Institute [Bethesda] (NCI-NIH), National Institutes of Health [Bethesda] (NIH), CIBER de Epidemiología y Salud Pública (CIBERESP), Russian Cancer Research Centre, Nofer Institute of Occupational Medicine (NIOM), National center for public health [Hungary], Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (MCMCC), Regional Authority of Public Health [Slovaquia] (RAPH), Ministry of Health of the Slovak Republic [Slovaquia], University of Liverpool, National Institute of Public Health [Romania] (INSP), Charles University [Prague] (CU), Masaryk University [Brno] (MUNI), Palacky University Olomouc, Ostravská univerzita / University of Ostrava, Utrecht University [Utrecht], Icahn School of Medicine at Mount Sinai [New York] (MSSM), Centre International de Recherche contre le Cancer - International Agency for Research on Cancer (CIRC - IARC), Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), This study was supported by the German Social Accident Insurance, grant number FP 271. Grant sponsors of the individual studies were the Canadian Institutes for Health Research and Guzzo-SRC Chair in Environment and Cancer, National Cancer Institute of Canada, Canadian Cancer Society, Occupational Cancer Research Centre, Workplace Safety and Insurance Board, Canadian Cancer Society, and Cancer Care Ontario, Grant sponsor: European Commission’s INCO Copernicus program, Grant number: IC15-CT96-0313, Grant sponsor: European Union Nuclear Fission Safety Program, Grant number: F14P-CT96-0055, Grant sponsors: French Agency of Health Security (ANSES), Fondation de France, French National Research Agency (ANR), National Institute of Cancer (INCA), Fondation pour la Recherche Medicale, French Institute for Public Health Surveillance (InVS), Health Ministry (DGS), Organization for the Research on Cancer (ARC), and FrenchMinistry of work, solidarity, and public function (DGT), Grant sponsor: Federal Ministry of Education, Science, Research, and Technology, Grant number: 01 HK 173/0), Grant sponsor: Federal Ministry of Science, Grant number: 01 HK 546/8, Grant sponsor: Ministry of Labour and Social Affairs, Grant number: IIIb7-27/13, Grant sponsor: Research Grants Council of the Hong Kong Special Administrative Region, China, Grant number: CUHK4460/03M, Grant sponsors: Environmental Epidemiology Program of the Lombardy Region, INAIL, Italian Association for Cancer Research, Region Piedmont, Compagnia di San Paolo, Lazio Region, Health Research Council of New Zealand, New Zealand Department of Labour, Lottery Health Research, Cancer Society of New Zealand, Grant sponsor: Polish State Committee for Scientific Research, Grant number: SPUB-M-COPERNICUS/P-05/DZ-30/99/2000, Grant sponsors: Instituto Universitario de Oncologia, Universidad de Oviedo, Asturias, Fondo de Investigacion Sanitaria (FIS) and Ciber de Epidemiologia y Salud Publica (CIBERESP), Swedish Council for Work Life Research and Swedish Environmental Protection Agency, Dutch Ministry of Health, Welfare and Sports, National Institute of Public Health and the Environment, and Europe Against Cancer Program, Roy Castle Foundation, and Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, Maryland., Nofer Institute of Occupational Medicine, Lodz, Poland, Courcelles, Michel, Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM), Helmholtz Zentrum München = German Research Center for Environmental Health, Università degli studi di Torino = University of Turin (UNITO), Università degli Studi di Padova = University of Padua (Unipd), One Health Chemisch, and dIRAS RA-2

Subjects
Genetics and Molecular Biology (all), Male, Lung Neoplasms, Economics, [SDV]Life Sciences [q-bio], Medizin, lcsh:Medicine, Social Sciences, MESH: Logistic Models, Sex Factor, cancer risk, Biochemistry, MESH: Occupational Exposure, Lung and Intrathoracic Tumors, lung tumor, Geographical Locations, Habits, Small Cell Lung Cancer, Biochemistry, Genetics and Molecular Biology (all), Agricultural and Biological Sciences (all), MESH: Risk Factors, Risk Factors, middle aged, Medicine and Health Sciences, Smoking Habits, Odds Ratio, Public and Occupational Health, lcsh:Science, health care economics and organizations, MESH: Aged, MESH: Middle Aged, adult, Age Factors, Socioeconomic Aspects of Health, educational statu, [SDV] Life Sciences [q-bio], Europe, Professions, female, Oncology, Anatomy, Research Article, Employment, MESH: Smoking, Canada, Histology, Logistic Model, sex difference, education, Jobs, Article, smoking, statistical model, Age Factor, MESH: Social Class, Sex Factors, MESH: Sex Factors, MESH: Canada, Occupational Exposure, Humans, controlled study, human, social cla, Aged, MESH: Age Factors, Behavior, MESH: Humans, meta analysi, Risk Factor, lcsh:R, disease association, high risk population, Small cell lung cancer, Smoking habits, Lung and intrathoracic tumors, Socioeconomic aspects of health, Cancers and Neoplasms, Biology and Life Sciences, case control study, lung carcinogenesi, social statu, MESH: Male, MESH: Odds Ratio, MESH: Lung Neoplasms, Health Care, Lung Neoplasm, lung cancer, Logistic Models, age, Social Class, Labor Economics, People and Places, lcsh:Q, Population Groupings, pathology, MESH: Europe, MESH: Female
Abstract

An association between low socioeconomic status (SES) and lung cancer has been observed in several studies, but often without adequate control for smoking behavior. We studied the association between lung cancer and occupationally derived SES, using data from the international pooled SYNERGY study. Twelve case-control studies from Europe and Canada were included in the analysis. Based on occupational histories of study participants we measured SES using the International Socio-Economic Index of Occupational Status (ISEI) and the European Socio-economic Classification (ESeC). We divided the ISEI range into categories, using various criteria. Stratifying by gender, we calculated odds ratios (OR) and 95% confidence intervals (CI) by unconditional logistic regression, adjusting for age, study, and smoking behavior. We conducted analyses by histological subtypes of lung cancer and subgroup analyses by study region, birth cohort, education and occupational exposure to known lung carcinogens. The analysis dataset included 17,021 cases and 20,885 controls. There was a strong elevated OR between lung cancer and low SES, which was attenuated substantially after adjustment for smoking, however a social gradient persisted. SES differences in lung cancer risk were higher among men (lowest vs. highest SES category: ISEI OR 1.84 (95% CI 1.61-2.09); ESeC OR 1.53 (95% CI 1.44-1.63)), than among women (lowest vs. highest SES category: ISEI OR 1.54 (95% CI 1.20-1.98); ESeC OR 1.34 (95% CI 1.19-1.52)). SES remained a risk factor for lung cancer after adjustment for smoking behavior. Funding: This study was supported by the German Social Accident Insurance, grant number FP 271. Grant sponsors of the individual studies were the Canadian Institutes for Health Research and Guzzo-SRC Chair in Environment and Cancer, National Cancer Institute of Canada, Canadian Cancer Society, Occupational Cancer Research Centre, Workplace Safety and Insurance Board, Canadian Cancer Society, and Cancer Care Ontario; Grant sponsor: European Commission’s INCO Copernicus program; Grant number: IC15-CT96-0313; Grant sponsor: European Union Nuclear Fission Safety Program; Grant number: F14P-CT96-0055; Grant sponsors: French Agency of Health Security (ANSES), Fondation de France, French National Research Agency (ANR), National Institute of Cancer (INCA), Fondation pour la Recherche Medicale, French Institute for Public Health Surveillance (InVS), Health Ministry (DGS), Organization for the Research on Cancer (ARC), and FrenchMinistry of work, solidarity, and public function (DGT); Grant sponsor: Federal Ministry of Education, Science, Research, and Technology; Grant number: 01 HK 173/0); Grant sponsor: Federal Ministry of Science; Grant number: 01 HK 546/8; Grant sponsor: Ministry of Labour and Social Affairs; Grant number: IIIb7-27/13; Grant sponsor: Research Grants Council of the Hong Kong Special Administrative Region, China; Grant number: CUHK4460/03M; Grant sponsors: Environmental Epidemiology Program of the Lombardy Region, INAIL, Italian Association for Cancer Research, Region Piedmont, Compagnia di San Paolo, Lazio Region, Health Research Council of New Zealand, New Zealand Department of Labour, Lottery Health Research, Cancer Society of New Zealand; Grant sponsor: Polish State Committee for Scientific Research; Grant number: SPUB-M-COPERNICUS/P-05/DZ-30/99/2000; Grant sponsors: Instituto Universitario de Oncologia, Universidad de Oviedo, Asturias, Fondo de Investigacion Sanitaria (FIS) and Ciber de Epidemiologia y Salud Publica (CIBERESP), Swedish Council for Work Life Research and Swedish Environmental Protection Agency, Dutch Ministry of Health, Welfare and Sports, National Institute of Public Health and the Environment, and Europe Against Cancer Program, Roy Castle Foundation, and Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, Maryland.

Published
2018

6. Exposure-Response Analyses of Asbestos and Lung Cancer Subtypes in a Pooled Analysis of Case-Control Studies

Author

Olsson, Ann C, Vermeulen, Roel, Schüz, Joachim, Kromhout, Hans, Pesch, Beate, Peters, Susan, Behrens, Thomas, Portengen, Lützen, Mirabelli, Dario, Gustavsson, Per, Kendzia, Benjamin, Almansa, Josue, Luzon, Veronique, Vlaanderen, Jelle, Stücker, Isabelle, Guida, Florence, Consonni, Dario, Caporaso, Neil, Landi, Maria Teresa, Field, John, Brüske, Irene, Wichmann, Heinz-Erich, Siemiatycki, Jack, Parent, Marie-Elise, Richiardi, Lorenzo, Merletti, Franco, Jöckel, Karl-Heinz, Ahrens, Wolfgang, Pohlabeln, Hermann, Plato, Nils, Tardón, Adonina, Zaridze, David, McLaughlin, John, Demers, Paul, Szeszenia-Dabrowska, Neonila, Lissowska, Jolanta, Rudnai, Peter, Fabianova, Eleonora, Stanescu Dumitru, Rodica, Bencko, Vladimir, Foretova, Lenka, Janout, Vladimir, Boffetta, Paolo, Bueno-de-Mesquita, Bas, Forastiere, Francesco, Brüning, Thomas, Straif, Kurt, LS IRAS EEPI GRA (Gezh.risico-analyse), LS IRAS EEPI EXAS (Arb.hyg+bl.st.kar.), Sub IRAS EEPI Algemeen, dIRAS RA-2, Nofer Institute of Occupational Medicine, Łódź, Poland, Olsson, A.C., Vermeulen, R., Schüz, J., Kromhout, H., Pesch, B., Peters, S., Behrens, T., Portengen, L., Mirabelli, D., Gustavsson, P., Kendzia, B., Almansa, J., Luzon, V., Vlaanderen, J., Stücker, I., Guida, F., Consonni, D., Caporaso, N., Landi, M.T., Field, J., Brüske, I., Wichmann, H.-E., Siemiatycki, J., Parent, M.-E., Richiardi, L., Merletti, F., Jöckel, K.-H., Ahrens, W., Pohlabeln, H., Plato, N., Tardon, A., Zaridze, D., McLaughlin, J., Demers, P., Szeszenia-Dabrowska, N., Lissowska, J., Rudnai, P., Fabianova, E., Stanescu Dumitru, R., Bencko, V., Foretova, L., Janout, V., Boffetta, P., Bueno-De-Mesquita, B., Forastiere, F., Brüning, T., Straif, K., LS IRAS EEPI GRA (Gezh.risico-analyse), LS IRAS EEPI EXAS (Arb.hyg+bl.st.kar.), Sub IRAS EEPI Algemeen, dIRAS RA-2, Centre International de Recherche contre le Cancer - International Agency for Research on Cancer (CIRC - IARC), Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), Karolinska Institutet [Stockholm], Institute for Risk Assessment Sciences, Utrecht University [Utrecht], Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), The University of Western Australia (UWA), University of Turin, Centre de recherche en épidémiologie et santé des populations (CESP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Sud - Paris 11 (UP11)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Université Paris-Sud - Paris 11 (UP11), Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, National Cancer Institute [Bethesda] (NCI-NIH), National Institutes of Health [Bethesda] (NIH), Institute of Translational Medicine, University of Liverpool, Helmholtz-Zentrum München (HZM), Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal (UdeM), Institut Armand Frappier (INRS-IAF), Réseau International des Instituts Pasteur (RIIP)-Institut National de la Recherche Scientifique [Québec] (INRS), Universität Duisburg-Essen [Essen], Bremen Institute for Prevention Research and Social Medicine (BIPS), CIBER de Epidemiología y Salud Pública (CIBERESP), Russian Cancer Research Centre, Public Health Ontario - Santé publique Ontario, Cancer Care Ontario, Nofer Institute of Occupational Medicine (NIOM), Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (MCMCC), National center for public health [Hungary], Regional Authority of Public Health [Slovaquia] (RAPH), Ministry of Health of the Slovak Republic [Slovaquia], National Institute of Public Health [Romania] (INSP), Charles University [Prague] (CU), Masaryk University [Brno] (MUNI), Palacky University Olomouc, Icahn School of Medicine at Mount Sinai [New York] (MSSM), National Institute for Public Health and the Environment [Bilthoven] (RIVM), Azienda Sanitaria Locale [ROMA] (ASL), The SYNERGY project is funded by the German Social Accident Insurance (DGUV), Grant FP 271. The original studies were funded as follows: in Canada by Canadian Institutes for Health Research and Guzzo-SRC Chair in Environment and Cancer, National Cancer Institute of Canada, Canadian Cancer Society, Occupational Cancer Research Centre, Workplace Safety and Insurance Board, Canadian Cancer Society, and Cancer Care Ontario, in France by the French Agency of Health Security (ANSES), Fondation de France, French National Research Agency (ANR), National Institute of Cancer (INCA), Fondation pour la Recherche Médicale, French Institute for Public Health Surveillance (InVS), Health Ministry (DGS), Organization for the Research on Cancer (ARC), and French Ministry of work, solidarity, and public function (DGT), in Germany by Federal Ministry of Education, Science, Research, and Technology (Grant 01 HK 173/0), Federal Ministry of Science (Grant 01 HK 546/8), and the Ministry of Labour and Social Affairs (Grant IIIb7-27/13), in Italy by Environmental Epidemiology Program of the Lombardy Region, INAIL, Italian Association for Cancer Research, Region Piedmont, Compagnia di San Paolo, and Lazio Region, in Poland by Polish State Committee for Scientific Research (Grant SPUB-M-COPERNICUS/P-05/ DZ-30/99/2000), in Czech Republic by MH CZ - DRO (MMCI, 00209805), in Spain by Instituto Universitario de Oncologia, Universidad de Oviedo, Asturias, Fondo de Investigacion Sanitaria (FIS) and Ciber de Epidemiologia y Salud Publica (CIBERESP), in Sweden by Swedish Council for Work Life Research and Swedish Environmental Protection Agency, in the Netherlands by Dutch Ministry of Health, Welfare and Sports, National Institute of Public Health and the Environment, and Europe Against Cancer Program, in the UK by Roy Castle Foundation, in the USA by Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, MD, the IARC multicenter study in Central and Eastern Europe was funded by the European Commission’s INCO Copernicus program (Contract IC15-CT96-0313)., and Joachim Schüz and Kurt Straif are part of a collaborative study with the State Russian Institute of Occupational Health (SRIOH) on asbestos and cancer risk, which includes financial support from SRIOH to IARC. Paolo Boffetta acted as expert witness for Edison SpA in asbestos-related litigation, outside the submitted work. Beate Pesch, Thomas Behrens, Benjamin Kendzia, and Thomas Brüning, as staff of the Institute for Prevention and Occupational Medicine (IPA), are employed at the 'Berufsgenossenschaft Rohstoffe und chemische Industrie' (BG RCI), a public body, which is a member of the study’s main sponsor, the German Social Accident Insurance (DGUV). IPA is an independent research institute of the Ruhr-Universität Bochum. The authors are independent from the German Social Accident Insurance in study design, access to the collected data, responsibility for data analysis and interpretation, and the right to publish

Subjects
Adult, Male, Canada, Pathology, medicine.medical_specialty, Lung Neoplasms, Epidemiology, [SDV]Life Sciences [q-bio], Population, Medizin, Cumulative Exposure, [SDV.CAN]Life Sciences [q-bio]/Cancer, medicine.disease_cause, Asbestos, 03 medical and health sciences, asbestos exposure, 0302 clinical medicine, Occupational Exposure, Odds Ratio, medicine, Humans, 030212 general & internal medicine, Lung cancer, education, Aged, education.field_of_study, business.industry, Occupational asbestos exposure, lung cancer, Smoking, Case-control study, Absolute risk reduction, Odds ratio, Middle Aged, Occupational Epidemiology, medicine.disease, Small Cell Lung Carcinoma, 030210 environmental & occupational health, Confidence interval, 3. Good health, Europe, lung cancer, Logistic Models, Case-Control Studies, ComputingMethodologies_DOCUMENTANDTEXTPROCESSING, Carcinoma, Squamous Cell, Female, business, Demography
Abstract

Supplemental Digital Content is available in the text., Background: Evidence is limited regarding risk and the shape of the exposure–response curve at low asbestos exposure levels. We estimated the exposure–response for occupational asbestos exposure and assessed the joint effect of asbestos exposure and smoking by sex and lung cancer subtype in general population studies. Methods: We pooled 14 case–control studies conducted in 1985–2010 in Europe and Canada, including 17,705 lung cancer cases and 21,813 controls with detailed information on tobacco habits and lifetime occupations. We developed a quantitative job-exposure-matrix to estimate job-, time period-, and region-specific exposure levels. Fiber-years (ff/ml-years) were calculated for each subject by linking the matrix with individual occupational histories. We fit unconditional logistic regression models to estimate odds ratios (ORs), 95% confidence intervals (CIs), and trends. Results: The fully adjusted OR for ever-exposure to asbestos was 1.24 (95% CI, 1.18, 1.31) in men and 1.12 (95% CI, 0.95, 1.31) in women. In men, increasing lung cancer risk was observed with increasing exposure in all smoking categories and for all three major lung cancer subtypes. In women, lung cancer risk for all subtypes was increased in current smokers (ORs ~two-fold). The joint effect of asbestos exposure and smoking did not deviate from multiplicativity among men, and was more than additive among women. Conclusions: Our results in men showed an excess risk of lung cancer and its subtypes at low cumulative exposure levels, with a steeper exposure–response slope in this exposure range than at higher, previously studied levels. (See video abstract at, http://links.lww.com/EDE/B161.)

Published
2017

7. Lung cancer risk among bakers, pastry cooks and confectionary makers: the SYNERGY study

Author

Maria Teresa Landi, Per Gustavsson, John R. McLaughlin, Hans Erich Wichmann, Tabea Treppmann, David Zaridze, Florence Guida, Kurt Straif, Roel Vermeulen, Nils Plato, Eleonora Fabianova, Lap Ah Tse, Marie-Élise Parent, Vladimir Janout, Peter Rudnai, Vladimir Bencko, Neil E. Caporaso, Ann Olsson, Neil Pearce, Adonina Tardón, Paolo Boffetta, Isabelle Stücker, Lorenzo Richiardi, Dario Consonni, Rodica Stanescu Dumitru, Andrea 't Mannetje, Thomas Behrens, Neonila Szeszenia-Dabrowska, Karl-Heinz Jöckel, Franco Merletti, Ignatius Tak-sun Yu, Bas Bueno-de-Mesquita, Dario Mirabelli, Simone Benhamou, Jolanta Lissowska, Hermann Pohlabeln, Hans Kromhout, Susan Peters, Lenka Foretova, John K. Field, Joachim Schüz, Irene Brüske, Lorenzo Simonato, Thomas Brüning, Wolfgang Ahrens, Beate Pesch, Benjamin Kendzia, Jack Siemiatycki, Paul A. Demers, Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Centre International de Recherche contre le Cancer - International Agency for Research on Cancer (CIRC - IARC), Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), The Institute of Environmental Medicine [Stockholm] (IMM), Karolinska Institutet [Stockholm], Institute for Medical Informatics, Biometry and Epidemiology, University Hospital of Essen, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Leibniz Association, Institute for Statistics, University of Bremen, Institute of Epidemiology I, German Research Center for Environmental Health-Helmholtz-Zentrum München (HZM), Cancer Epidemiology Unit, Université de Turin, Department of Environmental Medicine and Public Health, Universita degli Studi di Padova, Institute of Carcinogenesis, Russian Academy of Medical Sciences, The Nofer Institute of Occupational Medicine, National Institute of Environmental Health, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Regional Authority of Public Health [Slovaquia] (RAPH), Ministry of Health of the Slovak Republic [Slovaquia], Molecular Epidemiology of Cancer Unit, CIBER de Epidemiología y Salud Pública (CIBERESP), Roy Castle Lung Cancer Research Programme, University of Liverpool, National Institute of Public Health [Romania] (INSP), Institute of Hygiene and Epidemiology, Charles University [Prague] (CU)-1st Faculty of Medicine, Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute (RECAMO), Faculty of Medicine, Palacky University Olomouc, Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CR CHUM), Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal (UdeM)-Université de Montréal (UdeM), Institut Armand Frappier (INRS-IAF), Réseau International des Instituts Pasteur (RIIP)-Institut National de la Recherche Scientifique [Québec] (INRS), Cancer Care Ontario, Occupational Cancer Research Centre, National Cancer Institute [Bethesda] (NCI-NIH), National Institutes of Health [Bethesda] (NIH), Division of Environmental Epidemiology, Utrecht University [Utrecht]-Institute of Risk Assessment Sciences, Western Australian Institute for Medical Research, The University of Western Australia (UWA), Variabilité Génétique et Maladies Humaines, Institut Universitaire d'Hématologie (IUH), Université Paris Diderot - Paris 7 (UPD7)-Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de recherche en épidémiologie et santé des populations (CESP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Sud - Paris 11 (UP11)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), University Paris-Sud, Unit of Epidemiology, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, National Institute for Public Health and the Environment [Bilthoven] (RIVM), Centre for Public Health Research, Faculty of Epidemiology and Population Health [London], London School of Hygiene and Tropical Medicine (LSHTM), Division of Occupational and Environmental Health, JC School of Public Health and Primary Care, The Chinese University of Hong Kong [Hong Kong]-The Chinese University of Hong Kong [Hong Kong], The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai [New York] (MSSM), International Prevention Research Institute (IPRI), This study was supported by the German Social Accident Insurance, grant FP 271. Grant sponsors of the individual studies were the Canadian Institutes of Health Research and Guzzo-SRC Chair in Environment and Cancer, the Fondation de France, the German Federal Ministry of Education, Science, Research, and Technology and the Ministry of Labour and Social Affairs, the EC's INCO-COPERNICUS Program, the Polish State Committee for Science Research, the Roy Castle Foundation, the NIH/NCI/DCEG Intramural Research Program, Lombardy Region, INAIL and the European Union Nuclear Fission Safety Program, the Italian Association for Cancer Research, Region Piedmont, the Compagnia di San Paolo, the Europe Against Cancer Program, the Swedish Council for Work Life Research and the Swedish EPA, the University of Oviedo, the European Regional Development Fund and the State Budget of the Czech Republic (RECAMO, CZ.1.05/2.1.00/03.0101), CIBERESP and FISS-PI060604., Behrens, T., Kendzia, B., Treppmann, T., Olsson, A., Jöckel, K.-H., Gustavsson, P., Pohlabeln, H., Ahrens, W., Brüske, I., Wichmann, H.-E., Merletti, F., Mirabelli, D., Richiardi, L., Simonato, L., Zaridze, D., Szeszenia-Dabrowska, N., Rudnai, P., Lissowska, J., Fabianova, E., Tardón, A., Field, J., Dumitru, R.S., Bencko, V., Foretova, L., Janout, V., Siemiatycki, J., Parent, M.-E., McLaughlin, J., Demers, P., Landi, M.T., Caporaso, N., Kromhout, H., Vermeulen, R., Peters, S., Benhamou, S., Stücker, I., Guida, F., Consonni, D., Bueno-de-Mesquita, B., Mannetje, A.'., Pearce, N., Tse, L.A., Yu, I.T.-S., Plato, N., Boffetta, P., Straif, K., Schüz, J., Pesch, B., and Brüning, T.

Subjects
Male, xposure to occupational lung carcinogens, Lung Neoplasms, [SDV]Life Sciences [q-bio], Medizin, MESH: Logistic Models, Logistic regression, MESH: Occupational Exposure, baker, 0302 clinical medicine, Risk Factors, MESH: Risk Factors, Odds Ratio, Food Industry, smoking behaviour, baking-related occupation, Control subjects, 030210 environmental & occupational health, MESH: Case-Control Studies, MESH: Food Industry, Occupational Diseases, 030220 oncology & carcinogenesis, Smoking status, Female, MESH: Occupational Diseases, medicine.medical_specialty, Article, 03 medical and health sciences, Occupational Exposure, medicine, Humans, Occupations, Lung cancer, MESH: Occupations, MESH: Humans, business.industry, Public Health, Environmental and Occupational Health, Case-control study, Odds ratio, medicine.disease, MESH: Male, MESH: Odds Ratio, Surgery, MESH: Lung Neoplasms, lung cancer, Increased risk, Logistic Models, Case-Control Studies, business, MESH: Female, Demography
Abstract

Introduction Some studies have suggested increased lung cancer risks among bakers, however the results overall were inconsistent. The authors studied lung cancer risks among bakers and baking-related occupations in the SYNERGY pooled case–control database from 16 countries. Methods Occupation in a baking-related job was identified from the subjects’ job histories. ORs adjusted for log(age), study centre, smoking behaviour and ever employment in a job with known exposure to occupational lung carcinogens were calculated by unconditional logistic regression. Findings were stratified by sex, histological subtype of lung cancer and smoking status. Results 19 366 cases (15 606 men) and 23 670 control subjects (18 528 men) were included. 473 cases (415 men, 58 women) and 501 controls (437 men, 64 women) had ever worked in baking or a related job. We did not observe an increased risk for men in baking (OR 1.01; 95% CI 0.86 to 1.18). No linear trends were observed for duration of employment. Some results suggested increased lung cancer risks for women, for example, for working as a baker for >30 years and in never-smokers, but after exclusion of one study these increased risks disappeared. Discussion The findings from this study do not suggest increased lung cancer risks in baking-related professions.

Published
2013

8. Cigarette smoking and lung cancer-relative risk estimates for the major histological types from a pooled analysis of case-control studies

Author

Kurt Straif, Rodica Stanescu Dumitru, Lorenzo Simonato, Cristina Fortes, Adrian Cassidy, Karl-Heinz Jöckel, Lorenzo Richiardi, Vladimir Janout, Georg Johnen, Lenka Foretova, Irene Brüske, Vladimir Bencko, Jolanta Lissowska, Franco Merletti, Peter Rudnai, Benjamin Kendzia, Beate Pesch, Jack Siemiatycki, Charles M. Rudin, Heinz Erich Wichmann, Dario Consonni, David Zaridze, Marie-Élise Parent, Neonila Szeszenia-Dabrowska, Per Gustavsson, Wolfgang Ahrens, Isabelle M. Gross, Paul Brennan, Hermann Pohlabeln, Eleonora Fabianova, Neil E. Caporaso, Ann Olsson, Isabelle Stücker, Thomas Brüning, Paolo Boffetta, Maria Teresa Landi, Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), The Institute of Environmental Medicine [Stockholm] (IMM), Karolinska Institutet [Stockholm], Institute for Medical Informatics, Biometry, and Epidemiology, University Hospital of Essen, Bremen Institute for Prevention Research and Social Medicine, University of Bremen, International Agency for Cancer Research (IACR), Institute of Epidemiology, Helmholtz-Zentrum München (HZM), Cancer Epidemiology Unit, Université de Turin-CPO-Piemonte, Department of Environmental Medicine and Public Health, Universita degli Studi di Padova, Clinical Epidemiology Unit, IDI-IRCCS, Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CR CHUM), Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal (UdeM)-Université de Montréal (UdeM), Institut Armand Frappier (INRS-IAF), Institut National de la Recherche Scientifique [Québec] (INRS)-Réseau International des Instituts Pasteur (RIIP), Unit of Epidemiology, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico-Ospedale Maggiore Policlinico, Division of Cancer Epidemiology and Genetics, National Cancer Institute [Bethesda] (NCI-NIH), National Institutes of Health [Bethesda] (NIH)-National Institutes of Health [Bethesda] (NIH), Institute of Carcinogenesis, Russian Cancer Research Centre, Roy Castle Lung Cancer Research Programme, University of Liverpool-Cancer Research Centre, The Nofer Institute of Occupational Medicine, National Institute of Environment Health, The M Sklodowska-Curie Cancer Center, Institute of Oncology, Epidémiologie environnementale des cancers, Université Paris-Sud - Paris 11 (UP11)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de la Santé et de la Recherche Médicale (INSERM), Department of Occupational Health, Regional Authority of Public Health-Specialized State Health Institute, National Institute of Public Health [Romania] (INSP), Institute of Hygiene and Epidemiology, Charles University [Prague] (CU)-1st Faculty of Medicine, Masaryk Memorial Cancer Institute, Masaryk Memorial Cancer Institute (RECAMO), Department of Preventive Medicine, Faculty of Medicine-Palacky University Olomouc, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine [Baltimore], The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai [New York] (MSSM), International Prevention Research Institute (IPRI), Grant sponsor: German Social Accident Insurance, Grant number: FP 271, Grant sponsors: Canadian Institutes of Health Research and Guzzo-SRC Chair in Environment and Cancer, the Fondation de France, the German Federal Ministry of Education, Science, Research, and Technology and the Ministry of Labour and Social Affairs, EC's INCO-COPERNICUS Program, Polish State Committee for Science Research, Roy Castle Foundation, NIH/NCI/DCEG Intramural Research Program, Lombardy Region, INAIL and the European Union Nuclear Fission Safety Program, Italian Association for Cancer Research, Region Piedmont, Compagnia di San Paolo, Europe Against Cancer Program, the Swedish Council for Work Life Research and the Swedish EPA, Pesch, B., Kendzia, B., Gustavsson, P., Jöckel, K.-H., Johnen, G., Pohlabeln, H., Olsson, A., Ahrens, W., Gross, I.M., Brüske, I., Wichmann, H.-E., Merletti, F., Richiardi, L., Simonato, L., Fortes, C., Siemiatycki, J., Parent, M.-E., Consonni, D., Landi, M.T., Caporaso, N., Zaridze, D., Cassidy, A., Szeszenia-Dabrowska, N., Rudnai, P., Lissowska, J., Stücker, I., Fabianova, E., Dumitru, R.S., Bencko, V., Foretova, L., Janout, V., Rudin, C.M., Brennan, P., Boffetta, P., Straif, K., and Brüning, T.

Subjects
Male, Oncology, Cancer Research, Lung Neoplasms, Medizin, cigarette smoking, Tobacco smoke, 0302 clinical medicine, Prevalence, Child, 0303 health sciences, education.field_of_study, relative risk characterization, Smoking, Middle Aged, Prognosis, 3. Good health, Europe, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Adenocarcinoma, Female, tobacco smoke, Adult, Risk, Canada, medicine.medical_specialty, Adolescent, Population, [SDV.CAN]Life Sciences [q-bio]/Cancer, Article, Young Adult, 03 medical and health sciences, stem cells, Internal medicine, medicine, Humans, education, Lung cancer, Neoplasm Staging, 030304 developmental biology, Gynecology, cigarette smoking, lung cancer, relative risk characterization, tobacco smoke, stem cells, business.industry, Case-control study, Odds ratio, medicine.disease, Small Cell Lung Carcinoma, Confidence interval, respiratory tract diseases, lung cancer, lung cancer, cigarette smoking, Case-Control Studies, Relative risk, business
Abstract

International audience; Lung cancer is mainly caused by smoking, but the quantitative relations between smoking and histologic subtypes of lung cancer remain inconclusive. By using one of the largest lung cancer datasets ever assembled, we explored the impact of smoking on risks of the major cell types of lung cancer. This pooled analysis included 13,169 cases and 16,010 controls from Europe and Canada. Studies with population controls comprised 66.5% of the subjects. Adenocarcinoma (AdCa) was the most prevalent subtype in never smokers and in women. Squamous cell carcinoma (SqCC) predominated in male smokers. Age-adjusted odds ratios (ORs) were estimated with logistic regression. ORs were elevated for all metrics of exposure to cigarette smoke and were higher for SqCC and small cell lung cancer (SCLC) than for AdCa. Current male smokers with an average daily dose of >30 cigarettes had ORs of 103.5 (95% confidence interval (CI): 74.8-143.2) for SqCC, 111.3 (95% CI: 69.8-177.5) for SCLC and 21.9 (95% CI: 16.6-29.0) for AdCa. In women, the corresponding ORs were 62.7 (95% CI: 31.5-124.6), 108.6 (95% CI: 50.7-232.8) and 16.8 (95% CI: 9.2-30.6), respectively. Although ORs started to decline soon after quitting, they did not fully return to the baseline risk of never smokers even 35 years after cessation. The major result that smoking exerted a steeper risk gradient on SqCC and SCLC than on AdCa is in line with previous population data and biological understanding of lung cancer development.

Published
2012

Catalog

Books, media, physical & digital resources
See catalog results